Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients

Journal of the American Geriatrics Society

Volumn 50, Issue 1, 2002, Pages 117-124

  Wang, Philip S ^a   Levin, Raisa ^a   Zhao, Sean Z ^b   Avorn, Jerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Global Drug Surveillance and Outcomes Research   (United States)

Author keywords

Sudden death; Urinary antispasmodics; Ventricular arrhythmias

Indexed keywords

ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; CYSTOSPAS; CYSTOSPAS M; CYTOCHROME P450 3A4 INHIBITOR; CYTOCHROME P450 INHIBITOR; FLAVOXATE; HYOSCYAMINE; HYOSCYAMINE SULFATE; MACROLIDE; MECLOZINE; NEUROLEPTIC AGENT; OXYBUTYNIN; QUINOLONE DERIVATIVE; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

AGED; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; FEMALE; GENDER; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEGRO; RETROSPECTIVE STUDY; RISK FACTOR; SUDDEN DEATH; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; ARRHYTHMIA; CHOLINERGIC ANTAGONISTS; COHORT STUDIES; DEATH, SUDDEN; FEMALE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; NURSING HOMES; PARASYMPATHOLYTICS; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY INCONTINENCE;

EID: 0036142181     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50017.x     Document Type: Article

References (49)

1. The overactive bladder: An overview for primary care health providers
2. Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivity
3. Management of Acute and Chronic Urinary Incontinence in Adults
4. A study of the anticholinergic and antispasmodic activity of oxybutynin (Ditropan(R)) on rabbit detrusor
5. Oxybutynin: A new drug with analgesic and anticholinergic properties
6. Oxybutynin: A musculotropic antispasmodic drug with moderate anticholinergic action
7. The use of hyoscyamine as a hallucinogen and intoxicant
8. Flavoxate: A drug with smooth muscle relaxing activity
9. Snipping the thread of life; Antimuscarinic side effects of medications in the elderly
10. Change of autonomic influence on the heart immediately before the onset of spontaneous idiopathic ventricular tachycardia
11. Terodiline: A review of its pharmacological properties and therapeutic use in the treatment of urinary incontinence
12. Terodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval
13. Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence
14. Torsade de pointes complicating treatment with terodiline
15. Torsade de pointes ventricular tachycardia and terodiline
16. Effect of oxybutynin on the QTc interval in elderly patients with urinary incontinence
17. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis
18. Poisoning with oxybutynin
19. FDA strengthens warning label for propulsid
20. Use of terfenadine and contraindicated drugs
21. Risk of selected serious cardiac events among new users of antihistamines
22. Terfenadine-associated ventricular arrhythmias and QTc interval prolongation
23. Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-thecounter antihistamines, ibuprofen and clemastine
24. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs
25. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
26. Long QT syndrome during high-dose cisapride
27. Cisapride and fatal arrhythmia
28. St Anthony Hospital
29. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
30. Potentially fatal arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm
31. Arrthythmias and mortality in congestive heart failure
32. Sudden unexpected death in patients with congestive heart failure: A second frontier
33. Epidemiologic considerations in cardiac arrest and sudden cardiac death: Etiology and prehospital and posthospital outcomes
34. Precursors of sudden coronary death: Factors related to the incidence of sudden death
35. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment
36. Epidemiology of sudden cardiac death: Population characteristics, conditioning risk factors, and dynamic risk factors
37. Sudden coronary death: The Framingham study
38. Predisposing factor in sudden cardiac death in Tecumseh, Michigan: A prospective study
39. The epidemiology of sudden unexpected death: Risk factors for men and women in the Framingham Heart Study
40. Sudden coronary death in the United States: 1980-1985
41. Race differences in estimates of sudden coronary heart disease mortality, 1980-1988: The impact of ill-defined death
42. Anatomic substrate differences between black and white victims of sudden cardiac death: Hypertension, coronary heart disease, or both?
43. Sickle-cell trait as a risk factor for sudden death in physical training
44. Interaction of tolterodine with cholinergic muscarinic receptors in human detrusor